Abstract:
Methamphetamine (METH) is an abused psychostimulant that can cause psychotic symptoms, cognitive and psychomotor deficits, stroke, and death. METH‐induced neurotoxicity includes neural cell death which occurs via processes that resemble apoptosis. We have used cDNA array technology to investigate transcriptional responses that occur in the rodent brain after a toxic dose of the drug. These studies showed that the drug can cause an early pattern of gene induction which is characterized by changes in transcription factors. A more delayed response included changes in the expression of genes involved in DNA repair, regulation of trophic factors, and in cell death pathways. Interestingly, regulation of some of these transcription factors has been shown to be involved in controlling the expression of Fas ligand (FasL) which can trigger apoptosis in a number of models of cell death. Thus, these results indicate that METH can cause some of its degenerative effects, in part, via activation of a receptor‐mediated cell death pathway consequent to multiple transcription factor‐mediated FasL up‐regulation. When taken together, these observations indicate that METH‐induced toxicity results from the balance of pro‐death/protective mechanisms in the rodent brain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AICD:
-
activity-induced cell death
- AP-1:
-
activator protein-1
- AP-site:
-
apurinic/apyrimidinic site
- BER:
-
base excision repair
- DA:
-
dopamine
- DAT:
-
dopamine transporter
- FGF:
-
fibroblast growth factor
- IGF:
-
insulin growth factor
- MMR:
-
mismatch repair
- NER:
-
nucleotide excision repair
- OGG1:
-
8-oxo-guanine glycosylase-1
- ROS:
-
reactive oxygen species
- TGF:
-
transforming growth factor
- TH:
-
tyrosine hydroxylase
References
Ali SF, Imam SZ, Itzhak Y. 2005. Role of peroxynitrite in methamphetamine-induced dopaminergic neurodegeneration and neuroprotection by antioxidants and selective NOS inhibitors. Ann N Y Acad Sci 1053: 97–98.
Andegeko Y, et al. 2001. Nuclear retention of ATM at sites of DNA double strand breaks. J Biol Chem 276: 38224–38230.
Asanuma M, et al. 2004. Specific gene expression and possible involvement of inflammation in methamphetamine-induced neurotoxicity. Ann N Y Acad Sci 1025: 69–75.
Barnes DE, Lindahl T. 2004. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet 38: 445–476.
Barzilai A, Yamamoto K. 2004. DNA damage responses to oxidative stress. DNA Repair (Amst) 3: 1109–1115.
Beckmann AM, Wilce PA. 1997. Egr transcription factors in the nervous system. Neurochem Int 31: 477–510; discussion 517-476.
Buffenstein A, Heaster J, Ko P. 1999. Chronic psychotic illness from methamphetamine. Am J Psychiatry 156: 662.
Cadet JL, Brannock C. 1998. Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32: 117–131.
Cadet JL, et al. 2001. Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: Evidence from cDNA array. Synapse 41: 40–48.
Cadet JL, McCoy MT, Ladenheim B. 2002. Distinct gene expression signatures in the striata of wild-type and heterozygous c-fos knockout mice following methamphetamine administration: Evidence from cDNA array analyses. Synapse 44: 211–226.
Cadet JL, Ordonez SV, Ordonez JV. 1997. Methamphetamine induces apoptosis in immortalized neural cells: Protection by the proto-oncogene, bcl-2. Synapse 25: 176–184.
Dalton TP, Shertzer HG, Puga A. 1999. Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol 39: 67–101.
Deng X, Cadet JL. 1999. Methamphetamine administration causes overexpression of nNOS in the mouse striatum. Brain Res 851: 254–257.
Deng X, Cadet JL. 2000. Methamphetamine-induced apoptosis is attenuated in the striata of copper-zinc superoxide dismutase transgenic mice. Brain Res Mol Brain Res 83: 121–124.
Deng X, et al. 2002. Methamphetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway. Neuropharmacology 42: 837–845.
Deng X, Ladenheim B, Tsao LI, Cadet JL. 1999. Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity. J Neurosci 19: 10107–10115.
Dore G, Sweeting M. 2006. Drug-induced psychosis associated with crystalline methamphetamine. Australas Psychiatry 14: 86–89.
Dosch J, Kaina B. 1996. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability. Oncogene 13: 1927–1935.
Droin NM, Pinkoski MJ, Dejardin E, Green DR. 2003. Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses. Mol Cell Biol 23: 7638–7647.
Eisch AJ, Schmued LC, Marshall JF. 1998. Characterizing cortical neuron injury with Fluoro-Jade labeling after a neurotoxic regimen of methamphetamine. Synapse 30: 329–333.
Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863–14868.
Farrell M, Marsden J, Ali R, Ling W. 2002. Methamphetamine: Drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction 97: 771–772.
Fortini P, et al. 2003. 8-Oxoguanine DNA damage: At the crossroad of alternative repair pathways. Mutat Res 531: 127–139.
Fumagalli F, et al. 1999. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci 19: 2424–2431.
Fung H, Demple B. 2005. A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. Mol Cell 17: 463–470.
Gros L, Saparbaev MK, Laval J. 2002. Enzymology of the repair of free radicals-induced DNA damage. Oncogene 21: 8905–8925.
Haas S, Kaina B. 1995. c-Fos is involved in the cellular defence against the genotoxic effect of UV radiation. Carcinogenesis 16: 985–991.
Harvey DC, Lacan G, Tanious SP, Melega WP. 2000. Recovery from methamphetamine induced long-term nigrostriatal dopaminergic deficits without substantia nigra cell loss. Brain Res 871: 259–270.
He J, et al. 2004. Neuroprotective effects of olanzapine on methamphetamine-induced neurotoxicity are associated with an inhibition of hyperthermia and prevention of Bcl-2 decrease in rats. Brain Res 1018: 186–192.
Hirata H, Cadet JL. 1997. p53-knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies. J Neurochem 69: 780–790.
Hutsell SQ, Sancar A. 2005. Nucleotide excision repair, oxidative damage, DNA sequence polymorphisms, and cancer treatment. Clin Cancer Res 11: 1355–1357.
Imam SZ, et al. 2001. Methamphetamine-induced alteration in striatal p53 and bcl-2 expressions in mice. Brain Res Mol Brain Res 91: 174–178.
Itzhak Y, Martin JL, Ail SF. 2000. nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice. Neuroreport 11: 2943–2946.
Jayanthi S, et al. 2001. Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex. FASEB J 15: 1745–1752.
Jayanthi S, et al. 2004. Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J 18: 238–251.
Jayanthi S, et al. 2005. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc Natl Acad Sci USA 102: 868–873.
Jayanthi S, Ladenheim B, Cadet JL. 1998. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann N Y Acad Sci 844: 92–102.
Jayanthi S, McCoy MT, Ladenheim B, Cadet JL. 2002. Methamphetamine causes coordinate regulation of SRC, cas, crk, and the jun N-terminal kinase-jun pathway. Mol Pharmacol 61: 1124–1131.
Johnston L, O'Malley PM, Bachman JG, Schulenberg J. 2006. Monitoring the future national results on adolescent drug use: Overview of key findings, 2005. Bethesda, MD: (NIH Publication No. 06-5882).
Krasnova IN, McCoy MT, Ladenheim B, Cadet JL. 2002. cDNA array analysis of gene expression profiles in the striata of wild-type and Cu/Zn superoxide dismutase transgenic mice treated with neurotoxic doses of amphetamine. FASEB J 16: 1379–1388.
Lackinger D, Eichhorn U, Kaina B. 2001. Effect of ultraviolet light, methyl methanesulfonate and ionizing radiation on the genotoxic response and apoptosis of mouse fibroblasts lacking c-Fos, p53 or both. Mutagenesis 16: 233–241.
Latinis KM, Norian LA, Eliason SL, Koretzky GA. 1997. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J Biol Chem 272: 31427–31434.
La Voie MJ, Hastings TG. 1999. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine. J Neurosci 19: 1484–1491.
Li Y, Trush MA. 1993. DNA damage resulting from the oxidation of hydroquinone by copper: Role for a Cu(II)/Cu(I) redox cycle and reactive oxygen generation. Carcinogenesis 14: 1303–1311.
Li-Weber M, Krammer PH. 2002. The death of a T-cell: Expression of the CD95 ligand. Cell Death Differ 9: 101–103.
Li-Weber M, Laur O, Krammer PH. 1999. Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation. Eur J Immunol 29: 3017–3027.
Locksley RM, Killeen N, Lenardo MJ. 2001. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104: 487–501.
London ED, et al. 2004. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 61: 73–84.
Lotharius J, et al. 2005. Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 25: 6329–6342.
Macian F, Garcia-Rodriguez C, Rao A. 2000. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J 19: 4783–4795.
Matsuoka M, Wispriyono B, Igisu H. 2000. Increased cytotoxicity of cadmium in fibroblasts lacking c-fos. Biochem Pharmacol 59: 1573–1576.
McCann UD, et al. 1998. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 18: 8417–8422.
Mittelstadt PR, Ashwell JD. 1999. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells. J Biol Chem 274: 3222–3227.
Nagata S. 1999. Fas ligand-induced apoptosis. Annu Rev Genet 33: 29–55.
O'Dell SJ, Marshall JF. 2000. Repeated administration of methamphetamine damages cells in the somatosensory cortex: Overlap with cytochrome oxidase-rich barrels. Synapse 37: 32–37.
Pennypacker K. 1997. Transcription factors in brain injury. Histol Histopathol 12: 1125–1133.
Prolla TA, et al. 1994. MLH1, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast. Science 265: 1091–1093.
Qiu J, et al. 2002. Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J Neurosci 22: 3504–3511.
Ramana CV, Boldogh I, Izumi T, Mitra S. 1998. Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci USA 95: 5061–5066.
Ricaurte GA, Schuster CR, Seiden LS. 1980. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Res 193: 153–163.
Salzmann J, et al. 2003. Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice. Br J Pharmacol 140: 831–838.
Saparbaev M, Prakash L, Prakash S. 1996. Requirement of mismatch repair genes MSH2 and MSH3 in the RAD1–RAD10 pathway of mitotic recombination in Saccharomyces cerevisiae. Genetics 142: 727–736.
Scanlon KJ, et al. 1991. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Proc Natl Acad Sci USA 88: 10591–10595.
Sekine Y, et al. 2001. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry 158: 1206–1214.
Sekine Y, et al. 2003. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. Am J Psychiatry 160: 1699–1701.
Sekine Y, et al. 2006. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 63: 90–100.
Shaulian E, Karin M. 2002. AP-1 as a regulator of cell life and death. Nat Cell Biol 4: E131–E136.
Slupphaug G, Kavli B, Krokan HE. 2003. The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res 531: 231–251.
Sonsalla PK, Nicklas WJ, Heikkila RE. 1989. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243: 398–400.
Staszewski RD, Yamamoto BK. 2006. Methamphetamine-induced spectrin proteolysis in the rat striatum. J Neurochem 96: 1267–1276.
Stumm G, et al. 1999. Amphetamines induce apoptosis and regulation of bcl-x splice variants in neocortical neurons. FASEB J 13: 1065–1072.
Suzuki YJ. 2003. Growth factor signaling for cardioprotection against oxidative stress-induced apoptosis. Antioxid Redox Signal 5: 741–749.
Tanos T, et al. 2005. Phosphorylation of c-Fos by members of the p38 MAPK family. Role in the AP-1 response to UV light. J Biol Chem 280: 18842–18852.
Thiel G, Cibelli G. 2002. Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193: 287–292.
Thiriet N, Zwiller J, Ali SF. 2001. Induction of the immediate early genes egr-1 and c-fos by methamphetamine in mouse brain. Brain Res 919: 31–40.
Thomas DM, Francescutti-Verbeem DM, Liu X, Kuhn DM. 2004. Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment—an oligonucleotide microarray approach. J Neurochem 88: 380–393.
Tomkinson AE, Mackey ZB. 1998. Structure and function of mammalian DNA ligases. Mutat Res 407: 1–9.
Toth R, et al. 2001. Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor α and γ and involve nur77 in T cells. Eur J Immunol 31: 1382–1391.
Valko M, et al. 2004. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266: 37–56.
Varon R, et al. 1998. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93: 467–476.
Volkow ND, et al. 2001a. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21: 9414–9418.
Volkow ND, et al. 2001b. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158: 377–382.
Wagner GC, et al. 1980. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181: 151–160.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this entry
Cite this entry
Jayanthi, S., McCoy, M.T., Cadet, J.L. (2007). Molecular Mechanisms of Methamphetamine-Induced Neurotoxicity: Insights Obtained Through cDNA Array Analyses. In: Lajtha, A., Youdim, M.B.H., Riederer, P., Mandel, S.A., Battistin, L. (eds) Handbook of Neurochemistry and Molecular Neurobiology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-30377-2_10
Download citation
DOI: https://doi.org/10.1007/978-0-387-30377-2_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-30344-4
Online ISBN: 978-0-387-30377-2
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences